[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@BioCentury Avatar @BioCentury BioCentury

BioCentury posts on X about novartis, $googl the most. They currently have XXXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

Mentions: X #

Mentions Line Chart

Followers: XXXXXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #


Social category influence stocks XXXX% finance XXXX% technology brands XXXX%

Social topic influence novartis 1.43%, $googl XXXX%

Top accounts mentioned or mentioned by @jeff_cranmer @marketwirenews @sofinnovavcs @nvidia @usfdas @usfda @cincorpharma @albireopharma @wuxiapptec @wuxibiologics @seemacms @scottgottliebmd @pfizer @nociftw @biopharmajosh @cbtadvisors @flyingeagle86 @lcccc333 @fishburnsimone @akesoinc

Top assets mentioned Novartis AG (NVS) Alphabet Inc Class A (GOOGL)

Top Social Posts #


Top posts by engagements in the last XX hours

"Rare disease setbacks for Ultragenyx mid-stage win for Rhythm. Plus: Astrazeneca and Takeda preparing submissions after Phase III readouts in this weeks Clinical Report"
@BioCentury Avatar @BioCentury on X 2025-07-15 22:30:12 UTC 16.3K followers, XXX engagements

"Third patient dies from acute liver failure caused by a Sarepta gene therapy"
@BioCentury Avatar @BioCentury on X 2025-07-18 00:00:08 UTC 16.3K followers, 93K engagements

"BioCentury's latest biopharma Management Moves: Steve Bates longtime head of BIA named executive chair of U.K.s Office of Life Sciences. Plus: Novartis names Mazuk chief patient experience officer and updates from Seres and ABPI"
@BioCentury Avatar @BioCentury on X 2025-07-22 22:30:04 UTC 16.3K followers, XXX engagements

"BioCentury's latest in biopharma management moves: New leaders forJapan Bioindustry Association. Plus: Birgitte Stephensen retiring from Genmab as chief legal officer and updates from4D MolecularOruka andGenesis Research Group"
@BioCentury Avatar @BioCentury on X 2025-07-03 01:30:09 UTC 16.3K followers, XXX engagements

"BioCentury's latest management tracks: Stumpe an alum of Tempus and Google named chief tech officer at Danaher. Plus: Updates from Cardiff Regenics X-chem"
@BioCentury Avatar @BioCentury on X 2025-06-28 00:30:09 UTC 16.3K followers, XXX engagements